LONDON — Updated guidelines for the management of atrial fibrillation released by the European Society of Cardiology are revamping the approach to care for this complex, multifactorial disease. The ...

AliveCor has received an additional FDA 510(k) clearance, this time for an algorithm that allows its smartphone ECG to detect atrial fibrillation -- an abnormal heart rhythm that isn't always ...

Please provide your email address to receive an email when new articles are posted on . A recent study found that time-restricted eating was associated with a reduced risk for CVD among older women ...

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced it expanded its Phase III OCEANIC clinical development program for the investigational drug asundexian (BAY2433334) by initiating a third ...

UAB Division of Cardiothoracic Surgery Assistant Professor Panayotis Vardas, M.D., has co-authored the article, "The Society of Thoracic Surgeons 2023 clinical practice guidelines for the surgical ...

More people have atrial fibrillation (AFib) than any other kind of irregular heartbeat. And the numbers are only expected to go up as people live longer with heart conditions that go along with it.

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Atrial fibrillation is the most common arrhythmia worldwide, affecting millions of the general population.

The second focused update endorses dabigatran (Pradaxa), a new drug that like warfarin represents a first-line choice to prevent thromboembolism in AF. 2 The FDA approved dabigatran in October 2010.

REHOVOT, Israel, Dec. 15, 2022 /PRNewswire/ -- CardiaCare, a clinical stage digital therapeutic company developing the world's first non-invasive, personalized neuromodulation wearable for atrial ...